Oncolytics Biotech Inc

Stock Chart, Company Information, and Scan Results

$1.15(as of Feb 24, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Oncolytics Biotech Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.15
Ticker SymbolONCY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees28
CountyUSA
Market Cap$103.7M

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.

Oncolytics Biotech Inc In Our Stock Scanner

As of Feb 24, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cup and HandleScan Type: Chart Pattern Scans
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.